Recently, IFNγ has been shown to have obligate roles in cancer immunology.2 In this review, we have conducted an extensive literature search of recent 5‐year studies of the roles of IFNγ signaling in the immune responses in cancer patients as well as in the tumor‐bearing mice. The gene discussed is IFNG; the disease is neoplasm.